Company Portfolio

Sangamo Therapeutics

Patents indexed

Year range

2023

biotechgene_editingpharmaceuticalsoftware

Key Inventors

Siyuan Tan1 David Paschon1 Philip D. Gregory1 Edward J. Rebar1 Jeffrey C. Miller1 Lei Zhang1 Fyodor Urnov1

All Patents

Career timeline

1 patents, in 2023

Dot size = forward citations

Hover or tap any dot to see the patent. Larger dots indicate more forward citations — a proxy for downstream influence.

2023 — How Engineered TALE Proteins Can Edit Genes

US 11661612·2023

How Engineered TALE Proteins Can Edit Genes

This patent describes engineered DNA-binding proteins called TALEs, which are shortened and modified to precisely target and edit specific DNA sequences in cells, potentially for gene therapy.

Patent monitoring

Sangamo Therapeutics

1 patents, in 2023

Get notified when Sangamo Therapeutics files a new patent